B
Bio Green Med Solution, Inc. (BGMS)
NCM – Real Time Price. Currency in USD
1.00
0.00 (0.00%)
At close: Mar 27, 2026, 4:00 PM EDT
0.96
-0.04 (-3.50%)
After-hours: Mar 27, 2026, 4:11 PM EDT
Get all premium features to the best stock analysis tool
NCM – Real Time Price. Currency in USD
1.00
0.00 (0.00%)
At close: Mar 27, 2026, 4:00 PM EDT
0.96
-0.04 (-3.50%)
After-hours: Mar 27, 2026, 4:11 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 6.43 | 6.05 | 10 | |
| Quick ratio | 5.07 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | 420K | 43K | 81K |
| Gross Profit | -43K | -32K | 389K | 37K | 15K |
| Operating Income | -23M | -31M | -30M | -16M | -9M |
| Net Income | -19M | -21M | -23M | -11M | -7M |
| EBITDA | -23M | -31M | -30M | -16M | -9M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 150 | 9.09 | 8.0 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | 132.56 | 43.54 | 10 |
| Next year | 0 | 5.08 | 3.0 |
| Weighted average score | 5.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -88.31 | -33.66 | 58.9 | 5.5 |
| Y/Y | 710 | -26.82 | 96.97 | 85.85 | 7.8 |
| 3y average | 636.08 | 10.56 | 36.51 | 20.29 | 9.3 |
| 5y average | 781.25 | -19.95 | 43.11 | -11.04 | 5.5 |
| Weighted average score | 7.0 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $3.8M significantly exceed its total debt $5.0K, ensuring strong financial flexibility
Total current assets $6.4M exceed Total current liabilities $1.0M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$434.0K limits the company's ability to reinvest or pay down debt